AIM Rule 26
The following information is disclosed in accordance with the requirements under Rule 26 of the AIM Rules. Below we set out helpful details or links that will take you to the information you seek.
This information was last reviewed and updated on the 23rd March 2023.
Description of our business
A description of what our business does and how we do it can be found here.
The names of our directors and their biographical details
The names and biographical details of our current directors can be found in the leadership section and can be accessed by clicking here.
Directors' responsibilities on the Board and its Committees
The responsibilities of the members of the Board details of the committees of the Board can be found in our Governance section.
The Audit and Risk, Remuneration, Nomination and ESG Committees support the Board with governance, decision-making and its responsibilities. Membership details and the work of each Committee can be accessed by clicking on the relevant link:
Country of incorporation and main country of operation
Alliance Pharma plc is incorporated in England (Registration Number 04241478). Its main country of operation is the United Kingdom.
Current constitutional documents
Please click on the link below for the Articles of Association.
Details of exchanges and trading platforms
The Company's Ordinary Shares are listed on AIM (EPIC code: APH) and not on any other exchanges or trading platforms.
Number of securities in issue and significant shareholders
The number of 1p Ordinary Shares in issue and details of our significant shareholders can be found here. When this number changes, we notify the market in our Total Voting Rights announcements. The Company does not hold any Ordinary Shares in Treasury. Insofar as the Company is aware, the percentage of securities that is not in public hands as defined by Aim Rule 26 is 0.13%.
Details of any restrictions on the transfer of securities
There are no restrictions on the transfer of securities.
All our financial information, including the Company's annual and interim reports is available in our reports and presentations section here.
All regulatory and business news released and notified by the Company in the past 12 months can be found and accessed in our Investor News section here.
Admission documents and circulars
Each year the Company holds a General Meeting (AGM) at which shareholders are able to attend and meet the Board of Directors. Details of the Company's Annual General Meetings can be found on our AGM section of this website.
The Company's first admission document was issued on the 28 November 2003: Admission Document
On the 26 November 2015, the Company issued a Re-Admission Document dated 26 November 2015: Re-Admission Document 26 Nov 2015
On the 2 December 2015, the Company released an announcement in accordance with Rule 2 of the AIM Rules: Announcement Prior to Admission
On 8 August 2022, the Company released a circular relating to the change in Auditor.
Further details on the Company's arrangements in relation to Governance can be accessed here.
Advisers and share Registrars
Please click here for details of the Company's Nominated Adviser, Corporate brokers and share Registrars.
UK City Code on Takeovers and Mergers
Alliance Pharma PLC is subject to the UK City Code on Takeovers and Mergers.